A detailed history of Peregrine Asset Advisers, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Peregrine Asset Advisers, Inc. holds 12,240 shares of JNJ stock, worth $1.9 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
12,240
Previous 12,135 0.87%
Holding current value
$1.9 Million
Previous $1.77 Million 11.84%
% of portfolio
0.7%
Previous 0.73%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$145.48 - $167.38 $15,275 - $17,574
105 Added 0.87%
12,240 $1.98 Million
Q2 2024

Aug 09, 2024

BUY
$144.38 - $157.78 $866 - $946
6 Added 0.05%
12,135 $1.77 Million
Q1 2024

May 02, 2024

SELL
$155.22 - $162.74 $29,336 - $30,757
-189 Reduced 1.53%
12,129 $1.92 Million
Q4 2023

Feb 06, 2024

SELL
$145.6 - $158.88 $582 - $635
-4 Reduced 0.03%
12,318 $1.93 Million
Q3 2023

Oct 31, 2023

BUY
$155.75 - $174.48 $1.71 Million - $1.92 Million
10,993 Added 827.16%
12,322 $1.92 Million
Q2 2023

Aug 07, 2023

BUY
$154.35 - $166.11 $926 - $996
6 Added 0.45%
1,329 $219,000
Q1 2023

May 09, 2023

BUY
$151.05 - $180.26 $906 - $1,081
6 Added 0.46%
1,323 $205,000
Q4 2022

Feb 02, 2023

SELL
$160.2 - $179.79 $14,257 - $16,001
-89 Reduced 6.33%
1,317 $232,000
Q3 2022

Nov 09, 2022

BUY
$161.33 - $179.52 $967 - $1,077
6 Added 0.43%
1,406 $230,000
Q2 2022

Aug 09, 2022

BUY
$168.19 - $186.01 $840 - $930
5 Added 0.36%
1,400 $248,000
Q1 2022

May 05, 2022

BUY
$158.14 - $179.59 $790 - $897
5 Added 0.36%
1,395 $247,000
Q4 2021

Feb 09, 2022

BUY
$155.93 - $173.01 $935 - $1,038
6 Added 0.43%
1,390 $238,000
Q3 2021

Nov 09, 2021

SELL
$161.5 - $179.47 $257,431 - $286,075
-1,594 Reduced 53.53%
1,384 $224,000
Q2 2021

Aug 12, 2021

BUY
$159.48 - $171.07 $797 - $855
5 Added 0.17%
2,978 $490,000
Q1 2021

May 13, 2021

SELL
$153.07 - $170.48 $195,164 - $217,362
-1,275 Reduced 30.01%
2,973 $489,000
Q4 2020

Feb 04, 2021

BUY
$137.11 - $157.38 $685 - $786
5 Added 0.12%
4,248 $669,000
Q3 2020

Nov 13, 2020

SELL
$140.38 - $153.83 $251,982 - $276,124
-1,795 Reduced 29.73%
4,243 $632,000
Q2 2020

Aug 14, 2020

BUY
$128.81 - $155.51 $193,987 - $234,198
1,506 Added 33.23%
6,038 $849,000
Q1 2020

May 15, 2020

BUY
$111.14 - $153.99 $503,686 - $697,882
4,532 New
4,532 $595,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Peregrine Asset Advisers, Inc. Portfolio

Follow Peregrine Asset Advisers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Asset Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Asset Advisers, Inc. with notifications on news.